Customceutical Compounding Recalls Glutathione Injection Vials Due to Sterility Concerns
Customceutical Compounding is recalling specific lots of compounded Glutathione 200mg/mL injection vials because the FDA could not ensure the products were sterile.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating under the rubric. The hazard involves a lack of sterility assurance in an injectable product, which poses a significant risk of infection or serious injury.
Plain-English summary
Customceutical Compounding is voluntarily recalling four vials of compounded Glutathione 200mg/mL injection, available in 10 mL and 12 mL multidoses. The recall affects Lot # 02132019@25, which has an expiration date of May 14, 2019. The product was distributed nationwide in the United States.
The recall was initiated because the FDA identified a lack of assurance regarding the sterility of the injectable solution. For injectable medications, sterility is a critical safety requirement to prevent the introduction of harmful microorganisms into the body.
Consumers who possess this specific lot of Glutathione injection should stop using it immediately and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Glutathione 200mg/mL inj. a) 10 ML and b) 12 ML MULTIDOSE VIAL MDV Compounded. Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272
- Manufacturer
- Customceutical Compounding
- Category
- Drug — Compounded Injectable
- Affected units
- 4
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 02132019@25
- Exp 5/14/19
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 10 recalled by Customceutical Compounding under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 10 products in this recall →Related recalls
Same manufacturer · Customceutical Compounding
See all →- SevereCustomceutical Compounding Recalls Lipoplex Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-05-08
- SevereCustomceutical Compounding Recalls Test D Vials Due to Sterility Concerns
FDA (Drugs) · 2019-05-08
- SevereCustomceutical Compounding Recalls BPlex Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-05-08
- SevereCustomceutical Compounding Recalls Test D Vials Due to Sterility Concerns
FDA (Drugs) · 2019-05-08
- SevereCustomceutical Compounding Recalls BPlex Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-05-08
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- HighGlutathione Injectable Vials Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2022-07-20
- SevereFDA Recalls Glutathione Injectable Due to Sterility Concerns
FDA (Drugs) · 2013-06-12
- HighGlutathione Injectable Compounded Drug Recalled Due to Sterility Assurance Issues
FDA (Drugs) · 2022-07-20
- SevereGlutathione Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2015-09-23
- SevereFDA Recalls Injectable Glutathione Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-11-12
- SevereFDA Recalls Compounded Injectable Glutathione Due to Sterility Concerns
FDA (Drugs) · 2015-11-04